General Electric's 3-D mammography device, SenoClaire, has received FDA approval, a Reuters article reports. The device, which is designed to detect breast cancer through the combination of low radiation X-rays from multiple angles, offers a more comprehensive and complete mammogram compared to the...

MEDI-4736, AstraZeneca's new immuno-oncology drug will be tested in a Phase II trial in 48 patients with colorectal cancer, a Reuters article reports. The drug is designed to help the immune system fight tumors, and is currently being studied in lung, as well as head and neck cancer. AstraZeneca shares rose...

Karen Shayne and Judy Pearson, Co-Founders, Women Survivors Alliance, discuss how their organization solves issues regarding current care for female cancer survivors, including: Absence of available resources for doctors concerning women survivors specifically. No complete and cohesive care plan for...